Free Trial

Addus HomeCare Corporation (NASDAQ:ADUS) Position Boosted by Victory Capital Management Inc.

Addus HomeCare logo with Medical background

Victory Capital Management Inc. raised its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 40.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 136,283 shares of the company's stock after purchasing an additional 39,451 shares during the quarter. Victory Capital Management Inc. owned about 0.75% of Addus HomeCare worth $13,477,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Envestnet Asset Management Inc. raised its stake in Addus HomeCare by 9.4% in the 4th quarter. Envestnet Asset Management Inc. now owns 42,698 shares of the company's stock valued at $5,352,000 after purchasing an additional 3,659 shares during the last quarter. Bank of Montreal Can increased its stake in shares of Addus HomeCare by 17.4% during the 4th quarter. Bank of Montreal Can now owns 2,493 shares of the company's stock worth $312,000 after purchasing an additional 369 shares during the last quarter. Deutsche Bank AG boosted its holdings in Addus HomeCare by 50.0% in the 4th quarter. Deutsche Bank AG now owns 16,354 shares of the company's stock valued at $2,050,000 after purchasing an additional 5,448 shares during the period. Schroder Investment Management Group increased its position in shares of Addus HomeCare by 22.8% during the 4th quarter. Schroder Investment Management Group now owns 61,727 shares of the company's stock worth $7,795,000 after purchasing an additional 11,460 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Addus HomeCare by 1.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company's stock valued at $86,833,000 after purchasing an additional 10,434 shares during the period. Institutional investors and hedge funds own 95.35% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ADUS. Macquarie reaffirmed an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a report on Tuesday, June 10th. JMP Securities restated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Wednesday, July 16th. Finally, Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. Seven analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $142.57.

Read Our Latest Stock Analysis on Addus HomeCare

Insider Activity

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the transaction, the executive vice president directly owned 7,796 shares in the company, valued at $896,540. The trade was a 20.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 4.60% of the company's stock.

Addus HomeCare Stock Performance

NASDAQ:ADUS traded up $1.27 during mid-day trading on Friday, hitting $109.43. 104,356 shares of the company's stock traded hands, compared to its average volume of 190,373. The firm has a 50 day moving average of $112.36 and a two-hundred day moving average of $109.56. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $136.72. The firm has a market capitalization of $2.01 billion, a price-to-earnings ratio of 24.70, a price-to-earnings-growth ratio of 1.56 and a beta of 0.81. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.20.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The company had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. During the same period in the prior year, the business earned $1.21 earnings per share. The company's revenue for the quarter was up 20.3% compared to the same quarter last year. On average, equities analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines